Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Disease (ASCVD)”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Large-scale testing (Phase 3)Study completedNCT03399370
What this trial is testing

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDElevated Cholesterol
The Medicines Company 1,561
Not applicableNot Yet RecruitingNCT07462871
What this trial is testing

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

Who this might be right for
Atherosclerosis Cardiovascular DiseaseMetabolic SyndromeDyslipidaemia
Liverpool John Moores University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing

Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120
Post-approval studies (Phase 4)Study completedNCT03474562
What this trial is testing

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Who this might be right for
ASCVDImpaired Fasting GlucoseHypertension
Yuhan Corporation 100
Large-scale testing (Phase 3)Study completedNCT06005597
What this trial is testing

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

Who this might be right for
DyslipidemiasHypercholesterolemiaFamilial Hypercholesterolemia+2 more
NewAmsterdam Pharma 407
Post-approval studies (Phase 4)Study completedNCT05761444
What this trial is testing

Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients

Who this might be right for
Atherosclerotic Cardiovascular Disease
Organon and Co 137
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Large-scale testing (Phase 3)Looking for participantsNCT06930885
What this trial is testing

Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

Who this might be right for
Atherothrombotic DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)
Hospital do Coracao 7,713
Not applicableEnded earlyNCT05834673
What this trial is testing

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more
Monash University 6
Large-scale testing (Phase 3)Study completedNCT05142722
What this trial is testing

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

Who this might be right for
DyslipidemiasHigh CholesterolHypercholesterolemia+2 more
NewAmsterdam Pharma 2,530
Post-approval studies (Phase 4)Study completedNCT03494270
What this trial is testing

High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

Who this might be right for
ASCVD
Yuhan Corporation 270
Not applicableActive Not RecruitingNCT05726838
What this trial is testing

The Belgian REAL (BE.REAL) Registry

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 600
Testing effectiveness (Phase 2)Looking for participantsNCT07327840
What this trial is testing

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Who this might be right for
Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD. 204
Post-approval studies (Phase 4)Looking for participantsNCT06767774
What this trial is testing

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

Who this might be right for
ASCVDDiabetesStatin
Korea University Anam Hospital 2,000
Not applicableStudy completedNCT02341664
What this trial is testing

Patient and Provider Assessment of Lipid Management Registry

Who this might be right for
HyperlipidemiaHypercholesterolemiaCardiovascular Disease+14 more
Duke University 7,658
Post-approval studies (Phase 4)Enrolling By InvitationNCT05579626
What this trial is testing

Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

Who this might be right for
Pre DiabetesASCVD
Seung-Whan Lee, M.D., Ph.D. 4,000
Post-approval studies (Phase 4)Looking for participantsNCT07581808
What this trial is testing

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease (ASCVD)
University Medical Centre Ljubljana 60
Not applicableStudy completedNCT03427307
What this trial is testing

Serum Level of Lipopolysaccharide-binding Protein (LBP) and Atherosclerosis in Hemodialysis Patients

Who this might be right for
Systemic Inflammatory Response Syndrome
Tungs' Taichung Metroharbour Hospital 360
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Not applicableUnknownNCT05148182
What this trial is testing

Metabolomics Characterization of Biomarkers of ASCVD and Prediction Model

Who this might be right for
AtherosclerosisPrediction Model
Shanghai 10th People's Hospital 1,869
Next Page